[go: up one dir, main page]

Jia et al., 2025 - Google Patents

Dual responsive magnetic DCR3 nanoparticles: a new strategy for efficiently targeting hepatocellular carcinoma

Jia et al., 2025

Document ID
17483353690039367014
Author
Jia L
Dai Y
Xu Y
Sun H
Gao H
Hao H
Wang L
Xu J
Shang J
Li G
Xu Y
Feng L
Publication year
Publication venue
Small

External Links

Snippet

Hepatocellular carcinoma (HCC) is a major cause of cancer deaths globally. Unlike traditional molecularly targeted drugs, magnetically controlled drug delivery to micro/nanorobots enhances precision in targeting tumors, improving drug efficiency and …
Continue reading at onlinelibrary.wiley.com (other versions)

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51Nanocapsules; Nanoparticles
    • A61K9/5107Excipients; Inactive ingredients
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/48Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
    • A61K47/48769Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form
    • A61K47/48853Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form the form being a particulate, powder, adsorbate, bead, sphere
    • A61K47/48876Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form the form being a particulate, powder, adsorbate, bead, sphere the form being a solid micro- or nanoparticle having no hollow or gas-filled core

Similar Documents

Publication Publication Date Title
Sabit et al. Nanocarriers: a reliable tool for the delivery of anticancer drugs
Kim et al. Perspectives for improving the tumor targeting of nanomedicine via the EPR effect in clinical tumors
Palzer et al. Iron oxide nanoparticle-based hyperthermia as a treatment option in various gastrointestinal malignancies
D’Agata et al. Magnetic nanoparticles in the central nervous system: targeting principles, applications and safety issues
Sun et al. Gold nanoparticle-induced cell death and potential applications in nanomedicine
de Toledo et al. Iron oxide magnetic nanoparticles as antimicrobials for therapeutics
Al-Musawi et al. Design and synthesis of multi-functional superparamagnetic core-gold shell nanoparticles coated with chitosan and folate for targeted antitumor therapy
Tietze et al. Nanoparticles for cancer therapy using magnetic forces
Munir Nanomedicine penetration to tumor: challenges, and advanced strategies to tackle this issue
Yang et al. Preparation of folic acid-conjugated, doxorubicin-loaded, magnetic bovine serum albumin nanospheres and their antitumor effects in vitro and in vivo
Meng et al. Biomimetic immunomagnetic nanoparticles with minimal nonspecific biomolecule adsorption for enhanced isolation of circulating tumor cells
El-Sherbiny et al. Magnetic nanoparticles-based drug and gene delivery systems for the treatment of pulmonary diseases
Yang et al. Pilot study of targeting magnetic carbon nanotubes to lymph nodes
Sheng et al. Magnetically responsive microbubbles as delivery vehicles for targeted sonodynamic and antimetabolite therapy of pancreatic cancer
Owen et al. Magnetic targeting of microbubbles against physiologically relevant flow conditions
Jia et al. Dual responsive magnetic DCR3 nanoparticles: a new strategy for efficiently targeting hepatocellular carcinoma
Simón-Gracia et al. Peritoneal carcinomatosis targeting with tumor homing peptides
Friedrich et al. SPIONs and magnetic hybrid materials: Synthesis, toxicology and biomedical applications
Cristofolini et al. Hybrid polyelectrolyte/Fe3O4 nanocapsules for hyperthermia applications
Levada et al. Magnetic-assisted treatment of liver fibrosis
Li et al. Evaluation of tumor treatment of magnetic nanoparticles driven by extremely low frequency magnetic field
Novoselova et al. Submicron-sized nanocomposite magnetic-sensitive carriers: controllable organ distribution and biological effects
Chen et al. Augmented EPR effect post IRFA to enhance the therapeutic efficacy of arsenic loaded ZIF-8 nanoparticles on residual HCC progression
Deng et al. Dual targeting with cell surface electrical charge and folic acid via superparamagnetic Fe3O4@ Cu2–xS for photothermal cancer cell killing
Redolfi Riva et al. Enhanced in vitro magnetic cell targeting of doxorubicin-loaded magnetic liposomes for localized cancer therapy